G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 57 filers reported holding G1 THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,225,551 | -56.5% | 225,700 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $2,818,993 | +90.2% | 225,700 | +464.2% | 0.00% | 0.0% |
Q1 2018 | $1,482,000 | +86.6% | 40,000 | 0.0% | 0.00% | – |
Q4 2017 | $794,000 | -20.3% | 40,000 | 0.0% | 0.00% | – |
Q3 2017 | $996,000 | +42.7% | 40,000 | 0.0% | 0.00% | – |
Q2 2017 | $698,000 | – | 40,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |